122 related articles for article (PubMed ID: 14670976)
1. Deactylase inhibitors disrupt cellular complexes containing protein phosphatases and deacetylases.
Brush MH; Guardiola A; Connor JH; Yao TP; Shenolikar S
J Biol Chem; 2004 Feb; 279(9):7685-91. PubMed ID: 14670976
[TBL] [Abstract][Full Text] [Related]
2. In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation.
Matsuyama A; Shimazu T; Sumida Y; Saito A; Yoshimatsu Y; Seigneurin-Berny D; Osada H; Komatsu Y; Nishino N; Khochbin S; Horinouchi S; Yoshida M
EMBO J; 2002 Dec; 21(24):6820-31. PubMed ID: 12486003
[TBL] [Abstract][Full Text] [Related]
3. HDAC6 regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation in renal epithelial cells.
Liu W; Fan LX; Zhou X; Sweeney WE; Avner ED; Li X
PLoS One; 2012; 7(11):e49418. PubMed ID: 23152903
[TBL] [Abstract][Full Text] [Related]
4. Chemical Versatility in Catalysis and Inhibition of the Class IIb Histone Deacetylases.
Christianson DW
Acc Chem Res; 2024 Apr; 57(8):1135-1148. PubMed ID: 38530703
[TBL] [Abstract][Full Text] [Related]
5. Selectivity of Hydroxamate- and Difluoromethyloxadiazole-Based Inhibitors of Histone Deacetylase 6 In Vitro and in Cells.
Ptacek J; Snajdr I; Schimer J; Kutil Z; Mikesova J; Baranova P; Havlinova B; Tueckmantel W; Majer P; Kozikowski A; Barinka C
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902164
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma.
Marquard L; Gjerdrum LM; Christensen IJ; Jensen PB; Sehested M; Ralfkiaer E
Histopathology; 2008 Sep; 53(3):267-77. PubMed ID: 18671804
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological blockade of HDAC6 attenuates cancer progression by inhibiting IL-1β and modulating immunosuppressive response in OSCC.
Mahale A; Routholla G; Lavanya S; Sharma P; Ghosh B; Kulkarni OP
Int Immunopharmacol; 2024 May; 132():111921. PubMed ID: 38547770
[TBL] [Abstract][Full Text] [Related]
8. Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter.
Westendorf JJ; Zaidi SK; Cascino JE; Kahler R; van Wijnen AJ; Lian JB; Yoshida M; Stein GS; Li X
Mol Cell Biol; 2002 Nov; 22(22):7982-92. PubMed ID: 12391164
[TBL] [Abstract][Full Text] [Related]
9. Crebinostat facilitates memory formation.
Dama D; Sharma SK
Biochem Biophys Res Commun; 2024 May; 710():149872. PubMed ID: 38593621
[TBL] [Abstract][Full Text] [Related]
10. aPKC phosphorylation of HDAC6 results in increased deacetylation activity.
Du Y; Seibenhener ML; Yan J; Jiang J; Wooten MC
PLoS One; 2015; 10(4):e0123191. PubMed ID: 25860570
[TBL] [Abstract][Full Text] [Related]
11. Phosphatase inhibitor 2 promotes acetylation of tubulin in the primary cilium of human retinal epithelial cells.
Wang W; Brautigan DL
BMC Cell Biol; 2008 Nov; 9():62. PubMed ID: 19036150
[TBL] [Abstract][Full Text] [Related]
12. Structure-Based Discovery of A Small Molecule Inhibitor of Histone Deacetylase 6 (HDAC6) that Significantly Reduces Alzheimer's Disease Neuropathology.
Mondal P; Bai P; Gomm A; Bakiasi G; Lin CJ; Wang Y; Choi SH; Tanzi RE; Wang C; Zhang C
Adv Sci (Weinh); 2024 Jan; 11(1):e2304545. PubMed ID: 37990786
[TBL] [Abstract][Full Text] [Related]
13. Positive and negative regulation of the innate antiviral response and beta interferon gene expression by deacetylation.
Nusinzon I; Horvath CM
Mol Cell Biol; 2006 Apr; 26(8):3106-13. PubMed ID: 16581785
[TBL] [Abstract][Full Text] [Related]
14. Direct Amidation to Access 3-Amido-1,8-Naphthalimides Including Fluorescent Scriptaid Analogues as HDAC Inhibitors.
Hearn KN; Ashton TD; Acharya R; Feng Z; Gueven N; Pfeffer FM
Cells; 2021 Jun; 10(6):. PubMed ID: 34203745
[TBL] [Abstract][Full Text] [Related]
15. Neural deficits in a mouse model of PACS1 syndrome are corrected with PACS1- or HDAC6-targeting therapy.
Villar-Pazos S; Thomas L; Yang Y; Chen K; Lyles JB; Deitch BJ; Ochaba J; Ling K; Powers B; Gingras S; Kordasiewicz HB; Grubisha MJ; Huang YH; Thomas G
Nat Commun; 2023 Oct; 14(1):6547. PubMed ID: 37848409
[TBL] [Abstract][Full Text] [Related]
16. HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo.
Zhang Y; Li N; Caron C; Matthias G; Hess D; Khochbin S; Matthias P
EMBO J; 2003 Mar; 22(5):1168-79. PubMed ID: 12606581
[TBL] [Abstract][Full Text] [Related]
17. Identification of HDAC10, a novel class II human histone deacetylase containing a leucine-rich domain.
Tong JJ; Liu J; Bertos NR; Yang XJ
Nucleic Acids Res; 2002 Mar; 30(5):1114-23. PubMed ID: 11861901
[TBL] [Abstract][Full Text] [Related]
18. Tubulin acetylation: responsible enzymes, biological functions and human diseases.
Li L; Yang XJ
Cell Mol Life Sci; 2015 Nov; 72(22):4237-55. PubMed ID: 26227334
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase 6 suppression of renal tubular epithelial cell promotes interstitial mineral deposition via alpha-tubulin acetylation.
Li S; Wu W; Yang B; Liu Z; Duan X; Sun X; Liu H; Zhang S; Zhou Y; Wu W
Cell Signal; 2024 Apr; 116():111057. PubMed ID: 38242268
[TBL] [Abstract][Full Text] [Related]
20. Macrocyclic Octapeptide Binding and Inferences on Protein Substrate Binding to Histone Deacetylase 6.
Watson PR; Gupta S; Hosseinzadeh P; Brown BP; Baker D; Christianson DW
ACS Chem Biol; 2023 Apr; 18(4):959-968. PubMed ID: 37027789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
